Literature DB >> 12629514

Presenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44.

Daizo Murakami1, Isamu Okamoto, Osamu Nagano, Yoshiaki Kawano, Taisuke Tomita, Takeshi Iwatsubo, Bart De Strooper, Eiji Yumoto, Hideyuki Saya.   

Abstract

CD44 is the major adhesion molecule for the extracellular matrix components and is implicated in a wide variety of physiological and pathological processes including the regulation of tumor cell growth and metastasis. Our previous studies have shown that CD44 undergoes sequential proteolytic cleavages in the extracellular and transmembrane domains and the cleavage product derived from CD44 intramembranous cleavage acts as a signal transduction molecule. However, the underlying mechanism of the intramembranous cleavage of CD44 remains to be elucidated. In the present study, we report for the first time that CD44 is a substrate of the presenilin (PS)-dependent gamma-secretase. We demonstrate that the intramembranous cleavage of CD44 induced by 12-O-tetradecanoylphorbol 13-acetate (TPA) treatment or mechanical scraping is blocked by gamma-secretase inhibitors in U251MG cells and that this cleavage is also inhibited in PS-deficient mouse embryonic fibroblasts. Furthermore, we showed that PS1 is redistributed to ruffling areas of the plasma membrane similarly to CD44 after TPA treatment, supporting our biochemical observation that PS1 is involved in the intramembranous cleavage of CD44. Our present findings suggest important implications for understanding CD44-dependent signal transduction and a potential role of PS/gamma-secretase activity in the functional regulation of adhesion molecules.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629514     DOI: 10.1038/sj.onc.1206298

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  50 in total

1.  Sequential and gamma-secretase-dependent processing of the betacellulin precursor generates a palmitoylated intracellular-domain fragment that inhibits cell growth.

Authors:  Alexander Stoeck; Li Shang; Peter J Dempsey
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

Review 2.  Substrate specificity of gamma-secretase and other intramembrane proteases.

Authors:  A J Beel; C R Sanders
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

3.  Conditional forebrain inactivation of nicastrin causes progressive memory impairment and age-related neurodegeneration.

Authors:  Katsuhiko Tabuchi; Guiquan Chen; Thomas C Südhof; Jie Shen
Journal:  J Neurosci       Date:  2009-06-03       Impact factor: 6.167

Review 4.  Targeting γ-secretase in breast cancer.

Authors:  Jianxun Han; Qiang Shen
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-06-21

5.  Intracellular domain fragment of CD44 alters CD44 function in chondrocytes.

Authors:  Liliana Mellor; Cheryl B Knudson; Daisuke Hida; Emily B Askew; Warren Knudson
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

6.  In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver.

Authors:  Allal Ouhtit; Zakaria Y Abd Elmageed; Mohamed E Abdraboh; Tong F Lioe; Madhwa H G Raj
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

7.  CD74 is a member of the regulated intramembrane proteolysis-processed protein family.

Authors:  Shirly Becker-Herman; Galit Arie; Helena Medvedovsky; Anat Kerem; Idit Shachar
Journal:  Mol Biol Cell       Date:  2005-08-17       Impact factor: 4.138

Review 8.  Trafficking of receptor tyrosine kinases to the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Exp Cell Res       Date:  2008-10-11       Impact factor: 3.905

9.  Presenilin/gamma-secretase cleaves CD46 in response to Neisseria infection.

Authors:  Nathan J Weyand; Christine M Calton; Dustin L Higashi; Kristen J Kanack; Magdalene So
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

10.  Modulation of hyaluronan production by CD44 positive glioma cells.

Authors:  Marzenna Wiranowska; Sharron Ladd; Lynn C Moscinski; Bobbye Hill; Ed Haller; Katalin Mikecz; Anna Plaas
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.